Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 34 holding rows worth $249,082,343.

Accession
0001420506-24-000355
Filed
2024-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 35 entries on the cover page, a total value of $249,082,343 stated on the cover page (in dollars after the unit check, H1), rows summing to $249,082,343 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR827,294$33,629,501dollars as filed
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK4,050,714$28,436,012dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK2,782,797$19,841,343dollars as filed
Medtronic PlcG5960L103COM220,000$18,123,600dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM1,578,263$14,520,020dollars as filed
KURA ONCOLOGY INC COM50127T109Stock950,000$13,661,000dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock2,232,242$13,371,130dollars as filed
ADC THERAPEUTICS SAH0036K147COMMON STOCK6,471,800$10,743,188dollars as filed
ABCELLERA BIOLOGICS INC COM00288U106Stock1,700,000$9,707,000dollars as filed
QUIDELORTHO CORP COM219798105Stock118,920$8,764,404dollars as filed
PACIRA BIOSCIENCES INC COM695127100Stock258,424$8,719,226dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM293,301$8,658,246dollars as filed
PROTHENA CORP PLC SHSG72800108Stock229,539$8,341,447dollars as filed
OPTION CARE HEALTH INC COM NEW68404L201Stock148,800$5,013,072dollars as filed
GALAPAGOS NV36315X901SPON ADR120,000$4,878,000dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM35,900$4,730,184dollars as filed
UNIVERSAL HLTH SVCS INC CL B913903100Stock28,090$4,282,040dollars as filed
GRAPHITE BIO INC38870X104COM1,351,939$3,542,080dollars as filed
KEZAR LIFE SCIENCES INC49372L100COM3,365,333$3,188,316dollars as filed
NUVATION BIO INC COM CL A67080N101Stock2,050,000$3,095,500dollars as filed
ORTHOPEDIATRICS CORP68752L100COMMON STOCK95,000$3,088,450dollars as filed
PRIVIA HEALTH GROUP INC74276R102COM132,158$3,043,599dollars as filed
DEXCOM INC COM252131107Stock23,000$2,854,070dollars as filed
MURAL ONCOLOGY PUB LTD COG63365103ORD SHS418,505$2,477,550dollars as filed
PROTHENA CORP PLCG72800908SHS53,500$1,944,190dollars as filed
VERADIGM INC01988P108COMMON STOCK180,000$1,888,200dollars as filed
ORIC PHARMACEUTICALS INC68622P909CALL200,000$1,840,000dollars as filed
BARRETT BUSINESS SVCS INC068463108COM13,000$1,505,400dollars as filed
ERASCA INC COM29479A108Stock599,458$1,276,846dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW55,000$1,183,600dollars as filed
SHOCKWAVE MED INC82489T104COM5,000$952,800dollars as filed
DESIGN THERAPEUTICS INC25056L103COM280,000$742,000dollars as filed
BIOMEA FUSION INC09077A106CMN42,991$624,229dollars as filed
ALKERMES PLCG01767105SHS15,000$416,100dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-24-000355this filing2024-02-14acceptance time not in the bulk data set